Crestwood Advisors Group LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Crestwood Advisors Group LLC

  • $5.16 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 06, 2020
SELL
$0.67 - $0.96 $95,475 - $136,800
-142,500 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$0.63 - $2.27 $89,775 - $323,475
142,500 New
142,500 $323,000

Others Institutions Holding MTNB

# of Institutions
4
Shares Held
2.74M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $137M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email